Related Experiment Video
Updated: May 28, 2026
05:18
A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
Published on: February 17, 2023
Adipose tissue-derived stem cells ameliorate diabetic bladder dysfunction in a type II diabetic rat model
Haiyang Zhang1, Xuefeng Qiu, Alan W Shindel
1Minimally Invasive Urology Center, Provincial Hospital Affiliated to Shandong University, Jinan, China.
Stem Cells and Development
|October 20, 2011
Summary
Adipose tissue-derived stem cells (ADSCs) improved bladder function in diabetic rats. This regenerative therapy reduced cell death and preserved blood vessels, offering a potential treatment for diabetic bladder dysfunction.
Area of Science:
- Urology
- Regenerative Medicine
- Stem Cell Therapy
Background:
- Diabetes mellitus frequently causes urinary problems like diabetic bladder dysfunction (DBD).
- DBD stems from bladder muscle changes, nerve damage, and urothelial issues, often resisting treatment.
- Adipose tissue-derived stem cells (ADSCs) show potential for tissue regeneration in DBD.
Purpose of the Study:
- To evaluate ADSC efficacy in ameliorating diabetic bladder dysfunction in a rat model.
- To investigate the mechanisms underlying ADSC therapeutic effects on DBD.
Main Methods:
- Type 2 diabetes was induced in rats using a high-fat diet and streptozotocin.
- Rats received either ADSC treatment or a phosphate-buffered saline control.
- Voiding function, cell differentiation, apoptosis, and capillary networks were assessed.
Main Results:
- ADSC-treated rats showed improved voiding function compared to controls.
- While some ADSCs differentiated into smooth muscle, paracrine signaling was the primary mechanism.
- ADSCs reduced apoptosis and preserved the suburothelial capillary network.
Conclusions:
- ADSCs show promise for treating diabetic bladder dysfunction.
- Therapeutic effects are mediated by paracrine signaling, reducing cell death and protecting vasculature.
- ADSC therapy represents a potential regenerative approach for DBD.
